Amlogenyx

Biotech & Life Sciences · Somerville, United States · Founded 2023

Amlogenyx, a subsidiary of Ultragenyx Pharmaceutical, Inc., focuses on researching and developing new gene therapies for Alzheimer’s disease and other amyloid-related conditions

Valuation $0–100M

Total funding $10–50M

Unlock exact values

Company overview

Amlogenyx company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2023
Headquarters: Somerville, United States
Employees: —
Open positions: None listed
Dealroom signal: 0.0

client focusb2bsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorMedical ResearchsectorResearch and DevelopmentsectorSpinoutsectorBiotech and PharmasectorDT and LSsectorscience-based

Valuation & funding

Amlogenyx funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Aug 2024	$14M	$56M	Ultragenyx Pharmaceutical · GordonMD Global Investment	↗
SPINOUT✓Other financing	Oct 2023	$0	—	Ultragenyx Pharmaceutical	—

Showing 2 recorded eventsUnlock the complete deal history →

Comparisons

Amlogenyx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PRProfionicsInnovative diagnostic solutions leveraging biomarkers and AI to rapidly detect and treat sepsis	Stevenage, United Kingdom	Operational	3	—	—
CBCurve BiosciencesUnlocking the right data to help patients with chronic disease on their decades-long journey	Mountain View, United States	Operational
VTVasa TherapeuticsPrecision medicine for heart failure and healthy aging	Encinitas, United States	Operational
NSNeuracle ScienceRetrocious nervous disorders, such as Alzheimer's disease, have become a major problem in modern society as well as the entry into the aging business	Seoul, South Korea	Operational
GBGennao BioGennao Bio is pioneering the development of targeted nucleic acid therapeutics using its unique, non-viral GMAB platform technology	Hopewell, United States	Operational
YBY BiologicsY-Biologics is Korea's leading R&D biotech company specializing in antibody drug development	Daejeon, South Korea	Operational
IMImcyseSpecific immunotherapies for severe autoimmune diseases	Liège, Belgium	Operational
NTNxera Pharma UK \| Heptares TherapeuticsDevelops novel, small-molecule drugs for G-protein-coupled receptors	Great Abington, United Kingdom	Acquired

Showing 8 of the closest matchesCompare every metric →

Talent graph

Amlogenyx's talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Amlogenyx's cap table

Sourced from Dealroom's funding and investor records.

Seed 2 investors entered at this stage

GordonMD Global Investment

Ultragenyx Pharmaceutical

Global footprint

Where Amlogenyx has talent and traffic

Workforce by country

🇺🇸 United States · Somerville HQ

Book a demo for the full country breakdown

In the news

Latest news about Amlogenyx

Recent press, funding announcements, and product moves mentioning Amlogenyx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Amlogenyx

An AI-synthesized read of the highest-engagement posts about Amlogenyx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Amlogenyx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.